USD
+$0.00
(+0.00%
)At Close (As of Sep 18, 2025)
$70.58M
Market Cap
-
P/E Ratio
-9.13
EPS
$33.90
52 Week High
$1.98
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | -$4M |
Total Revenue | $0 |
Cost Of Revenue | $4M |
Costof Goods And Services Sold | $4M |
Operating Income | -$26M |
Selling General And Administrative | $7.8M |
Research And Development | $18M |
Operating Expenses | $22M |
Investment Income Net | - |
Net Interest Income | -$746K |
Interest Income | - |
Interest Expense | $746K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $4M |
Income Before Tax | -$27M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$27M |
Comprehensive Income Net Of Tax | - |
Ebit | -$26M |
Ebitda | -$22M |
Net Income | -$27M |
Field | Value (USD) |
---|---|
Total Assets | $27M |
Total Current Assets | $6.1M |
Cash And Cash Equivalents At Carrying Value | $4.7M |
Cash And Short Term Investments | $4.7M |
Inventory | $1M |
Current Net Receivables | - |
Total Non Current Assets | $21M |
Property Plant Equipment | $17M |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $165K |
Intangible Assets Excluding Goodwill | $165K |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | $3.5K |
Other Current Assets | $298K |
Other Non Current Assets | - |
Total Liabilities | $14M |
Total Current Liabilities | $4.6M |
Current Accounts Payable | $1.4M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $4.5M |
Total Non Current Liabilities | $9.5M |
Capital Lease Obligations | $12M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $12M |
Other Current Liabilities | -$1.3M |
Other Non Current Liabilities | $125K |
Total Shareholder Equity | $13M |
Treasury Stock | - |
Retained Earnings | -$514M |
Common Stock | $638K |
Common Stock Shares Outstanding | $2M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$19M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $4M |
Capital Expenditures | $95K |
Change In Receivables | - |
Change In Inventory | -$173K |
Profit Loss | - |
Cashflow From Investment | -$108K |
Cashflow From Financing | $20M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | $24M |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$27M |
Field | Value (USD) |
---|---|
Gross Profit | -$4M |
Total Revenue | $0 |
Cost Of Revenue | $4M |
Costof Goods And Services Sold | $4M |
Operating Income | -$26M |
Selling General And Administrative | $7.8M |
Research And Development | $18M |
Operating Expenses | $22M |
Investment Income Net | - |
Net Interest Income | -$746K |
Interest Income | - |
Interest Expense | $746K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $4M |
Income Before Tax | -$27M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$27M |
Comprehensive Income Net Of Tax | - |
Ebit | -$26M |
Ebitda | -$22M |
Net Income | -$27M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
CEL-SCI Corporation is dedicated to the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company is headquartered in Vienna, Virginia.